|
Market Closed -
NSE India S.E.
05:41:04 14/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 2,318.40 INR | -0.07% |
|
+1.72% | +13.92% |
| 03/08 | Glenmark Pharmaceuticals Limited, Q1 2027 Earnings Call, Aug 03, 2026 | |
| 31/07 | India's Glenmark Pharma posts higher quarterly profit on strong demand | RE |
| Market Cap | 65TCr 684.21Cr 590.95Cr 555.31Cr 505.03Cr 949.49Cr 965.14Cr 6.51TCr 2.54TCr 33TCr 2.57TCr 2.51TCr 1,08900Cr | P/E 2026 |
44.2x | P/E 2027 * | 28.2x |
|---|---|---|---|---|---|
| Enterprise Value | 61TCr 643.11Cr 555.46Cr 521.96Cr 474.7Cr 892.46Cr 907.18Cr 6.12TCr 2.39TCr 31TCr 2.41TCr 2.36TCr 1,02300Cr | EV / Sales 2026 |
3.51x | EV / Sales 2027 * | 3.81x |
| Free-Float |
51.04% | Yield 2026 |
0.12% | Yield 2027 * | 0.16% |
Last Transcript: Glenmark Pharmaceuticals Limited
| 1 day | -0.07% | ||
| 1 week | +1.72% | ||
| Current month | +3.78% | ||
| 1 month | +0.58% | ||
| 3 months | -0.95% | ||
| 6 months | +16.06% | ||
| Current year | +13.92% |
| 1 week | 2,245 |  | 2,341.6 |
| 1 month | 2,162 | | 2,341.6 |
| Current year | 1,842 | | 2,474 |
| 1 year | 1,792.6 | | 2,474 |
| 3 years | 722.1 | | 2,474 |
| 5 years | 348.5 | | 2,474 |
| 10 years | 161.65 | | 2,474 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 01/01/2000 | |
Anurag Mantri
DFI | Director of Finance/CFO | 54 | 27/05/2025 |
Indrajit Bose
PSD | President | - | 15/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Cherylann Pinto
BRD | Director/Board Member | 58 | - |
| Chairman | 56 | 12/05/2011 | |
| Director/Board Member | 85 | 14/08/2009 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.07% | +1.72% | +13.39% | +190.65% | 685.99Cr | |
| -0.10% | -0.77% | +17.58% | +70.16% | 4.86TCr | |
| -3.26% | -5.31% | +53.19% | +117.23% | 4.1TCr | |
| -0.60% | -0.94% | -7.29% | +17.35% | 1.23TCr | |
| -2.75% | +1.88% | +14.81% | +76.92% | 1.22TCr | |
| -0.19% | -0.38% | +30.40% | +135.91% | 908.17Cr | |
| +1.56% | +5.52% | +23.46% | +39.78% | 740.77Cr | |
| +0.52% | +2.08% | +40.75% | -12.45% | 712.8Cr | |
| -2.51% | -3.14% | -27.46% | +24.20% | 591.75Cr | |
| +1.61% | +5.26% | +36.74% | +111.25% | 472.99Cr | |
| Average | -0.58% | +1.77% | +19.56% | +77.10% | 1.55TCr | |
| Weighted average by Cap. | -1.12% | +1.13% | +25.56% | +82.35% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 15TCr 160.12Cr 138.3Cr 129.96Cr 118.19Cr 222.2Cr 225.87Cr 1.52TCr 595.36Cr 7.67TCr 601.18Cr 588.13Cr 25TCr | 17TCr 175.61Cr 151.68Cr 142.53Cr 129.62Cr 243.7Cr 247.72Cr 1.67TCr 652.96Cr 8.41TCr 659.34Cr 645.03Cr 28TCr |
| Net income | 2.05TCr 21Cr 19Cr 17Cr 16Cr 30Cr 30Cr 204.19Cr 80Cr 1.03TCr 81Cr 79Cr 3.42TCr | 2.31TCr 24Cr 21Cr 20Cr 18Cr 34Cr 34Cr 229.84Cr 90Cr 1.16TCr 91Cr 89Cr 3.85TCr |
| Net Debt | -3.93TCr -41Cr -35Cr -33Cr -30Cr -57Cr -58Cr -390.78Cr -152.79Cr -1.97TCr -154.28Cr -150.93Cr -6.54TCr | -1.45TCr -15Cr -13Cr -12Cr -11Cr -21Cr -21Cr -143.94Cr -56Cr -724.77Cr -57Cr -56Cr -2.41TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/26/14 | ₹2,318.40 | -0.07% | 6,29,081 |
| 13/26/13 | ₹2,320.00 | +1.31% | 4,13,167 |
| 12/26/12 | ₹2,290.00 | +0.62% | 4,64,575 |
| 11/26/11 | ₹2,276.00 | +1.10% | 2,84,670 |
| 10/26/10 | ₹2,251.30 | -1.22% | 2,57,787 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLENMARK Stock
Select your edition
All financial news and data tailored to specific country editions
